JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ding, Y.
Right arrow Articles by Vaziri, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ding, Y.
Right arrow Articles by Vaziri, N. D.

Vol. 292, Issue 2, 606-609, February 2000

Nifedipine and Diltiazem but Not Verapamil Up-Regulate Endothelial Nitric-Oxide Synthase Expression

Yaoxian Ding and Nosratola D. Vaziri

Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine, Irvine, California.

We have recently shown that felodipine, a long-acting dihydropyridine L-type calcium channel blocker (CCB), up-regulates nitric oxide (NO) production and endothelial NO synthase (eNOS) expression and activity in cultured endothelial cells as well as in animals with chronic renal failure. This study was intended to compare the effects of prototypes of the three classes of L-type CCBs on the NO system in cultured human coronary artery endothelial cells. Thus, cultured endothelial cells were incubated either with nifedipine, diltiazem, or verapamil for 24 h at 10-5 to 10-7 M concentrations. Cells incubated with inactive vehicle served as controls. NO production, as discerned from total nitrate plus nitrite recovered in the medium, was significantly increased by nifedipine (P < .03) and by diltiazem (P < .05). However, NO production remained unchanged with verapamil (P = NS). Similarly, eNOS protein abundance was increased significantly by nifedipine (P < .05) and diltiazem (P < .05). In contrast, eNOS expression was not changed by verapamil (P = NS). Likewise, NOS activity, as measured from [3H]L-arginine to [3H]L-citrulline conversion, significantly increased with nifedipine (P < .01) and diltiazem (P < .01). However, incubation with verapamil failed to alter NOS activity of the cultured endothelial cells (P = NS). We concluded that prototypes of dihydropyridine and benzothiazepine classes, but not phenylalkylamine class of CCBs, up-regulate the NO system. This may, in part, account for the different biological properties of these agents.

0022-3565/00/2922-0606$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
E. Podjarny, G. Hasdan, J. Bernheim, G. Rashid, J. Green, Z. Korzets, and J. Bernheim
Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats
Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2223 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. C. Brown, K. S. Mark, R. D. Egleton, and T. P. Davis
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1045 - C1052.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H. Lenasi, K. Kohlstedt, B. Fichtlscherer, A. Mulsch, R. Busse, and I. Fleming
Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495
Cardiovasc Res, October 1, 2003; 59(4): 844 - 853.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Kagota, A. Tamashiro, Y. Yamaguchi, K. Nakamura, and M. Kunitomo
High Salt Intake Impairs Vascular Nitric Oxide/Cyclic Guanosine Monophosphate System in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 344 - 351.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. J. Ignarro, C. Napoli, and J. Loscalzo
Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview
Circ. Res., January 11, 2002; 90(1): 21 - 28.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, and T. Godfraind
Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats
Hypertension, April 1, 2001; 37(4): 1124 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. D. Vaziri and Y. Ding
Effect of Lead on Nitric Oxide Synthase Expression in Coronary Endothelial Cells : Role of Superoxide
Hypertension, February 1, 2001; 37(2): 223 - 226.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.